Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Головные боли в общеврачебной практике
Головные боли в общеврачебной практике
Табеева Г.Р. Головные боли в общеврачебной практике. Терапевтический архив. 2022;94(1):114–121.
DOI: 10.26442/00403660.2022.01.201325
DOI: 10.26442/00403660.2022.01.201325
DOI: 10.26442/00403660.2022.01.201325
________________________________________________
DOI: 10.26442/00403660.2022.01.201325
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
В первичном звене медико-санитарной помощи наблюдается основная часть пациентов с первичными головными болями – ГБ (цефалгиями). Оптимальный диагностический алгоритм подразумевает исключение потенциально опасных причин ГБ и вторичных цефалгий, требующих специфического лечения. Верификация формы первичной ГБ осуществляется клинически, не требует дополнительных методов диагностики и основывается на использовании критериев Международной классификации ГБ. Среди всех цефалгий в общей клинической практике подавляющее большинство случаев представлено четырьмя формами: мигрень, ГБ напряжения, кластерная ГБ и лекарственно-индуцированная ГБ. Комплексное применение современных методов фармакологического и нефармакологического лечения с использованием профилактических стратегий обеспечивает высокую эффективность ведения пациентов с ГБ.
Ключевые слова: первичные головные боли, вторичные головные боли, мигрень, головная боль напряжения, кластерная головная боль, лекарственно-индуцированная головная боль
Keywords: primary headaches, secondary headaches, migraine, tension type headache, cluster headache, medication overuse headache
Ключевые слова: первичные головные боли, вторичные головные боли, мигрень, головная боль напряжения, кластерная головная боль, лекарственно-индуцированная головная боль
________________________________________________
Keywords: primary headaches, secondary headaches, migraine, tension type headache, cluster headache, medication overuse headache
Полный текст
Список литературы
1. Atlas of headache disorders and resources in the world. A collaborative project of World Health Organization and Lifting The Burden. World Health Organization, 2011.
2. GBD 2019 Diseases and Injuries Collaborators. Global burden of
369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. DOI:10.1016/S0140-6736(20)30925-9
3. Martelletti P, Luciani M, Spuntarelli V, Bentivegna E. Deprescribing in migraine. Expert Opin Drug Saf. 2021;20(6):623-5. DOI:10.1080/14740338.2021.1907342
4. GBD 2016 Headache Collaborators. Global, Regional, and National Burden of Migraine and Tension-Type Headache, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-76. DOI:10.1016/S1474-4422(18)30322-3
5. Steiner TJ, Stovner LJ, Jensen R, et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137. DOI:10.1186/s10194-020-01208-0
6. Latinovic R, Gulliford M, Ridsdale L. Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry. 2006;77(3):385-7. DOI:10.1136/jnnp.2005.073221
7. Лебедева Е.Р., Кобзева Н.Р., Гилев Д.В., Олесен Е. Анализ качества диагностики и лечения первичной головной боли в разных социальных группах Уральского региона. Неврология, нейропсихиатрия, психосоматика. 2015;1:19-26 [Lebedeva ER, Kobzeva NR, Gilev DV, Olesen E. Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural Region. Neurology, Neuropsychiatry, Psychosomatics. 2015;1:19-26 (in Russian)]. DOI:10.14412/2074-2711-2015-1-19-26
8. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193-210. DOI:10.1111/j.1468-2982.2007.01288.x
9. Lucas C, Geraud G, Valade D, et al. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French Nationwide Population-Based Survey. Headache. 2006;46:715-25. DOI:10.1111/j.1526-4610.2006.00430.x
10. Ковальчук Н.А., Кирьянова Е.А., Табеева Г.Р. Приверженность терапии пациентов с мигренью (по данным интернет-опроса). Неврология, нейропсихиатрия, психосоматика. 2021;13(4):81-7 [Kovalchuk NA, Kiryanova EA, Tabeeva GR. Medication adherence in migraine patients (data of an online survey). Neurology, Neuropsychiatry, Psychosomatics. 2021;13(4):81-7 (in Russian)].DOI:10.14412/2074- 2711-2021-4-81-87
11. McNeil M. Headaches in Adults in Primary Care: Evaluation, Diagnosis, and Treatment. Med Clin North Am. 2021;105(1):39-53. DOI:10.1016/j.mcna.2020.09.005
12. Fejes E, Feher G, Gurdan Z, et al. Characteristics of Patients Referred To A Specialized Headache Clinic. Sci Rep. 2020;10(1):1146. DOI:10.1038/s41598-020-58234-w
13. Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53(3):427-36. DOI:10.1111/head.12074
14. Green LA, Phillips RL, Fryer GE. The nature of primary medical care. In: Oxford Textbook of Primary Medical Care. Oxford University Press, Oxford, UK, 2005.
15. BeckerL A, Iverson DC, Reed FM, et al. Study of Headache in North America in primary care. J R Coll Gen Pract. 1987;37:400-3.
16. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018;38(1):1-211. DOI:10.1177/0333102417738202
17. Steiner TJ, Jensen R, Katsarava Z, et al. Aids to management of headache disorders in primary care (2nd edition). J Headache Pain. 2019;20:57.
DOI:10.1186/s10194-018-0899-2
18. Стайнер Т.Дж., Пемелера К., Йенсен Р., и др. Европейские принципы ведения пациентов с наиболее распространенными формами головной боли в общей практике. Практическое руководство для врачей. Пер. с англ. Ю.Э. Азимовой, В.В. Осиповой; науч. ред. В.В. Осипова, Т.Г. Вознесенская, Г.Р. Табеева. М., 2010 [Steiner TJ, Paemeleire K, Jensen R, et al. European principles of management of common headache disorders in primary care. J Headache Pain. 2007;8(Suppl. 1)].
19. Becker WJ, Findlay T, Moga C, et al. Guideline for primary care management of headache in adults. Can Fam Physician. 2015;61(8):670-9. PMID: 26273080; PMCID: PMC4541429
20. Kernick D, Stapley S, Hamilton W. GPs' classification of headache: is primary headache underdiagnosed? Br J Gen Pract. 2008;58(547):102-4. DOI:10.3399/bjgp08X264072
21. Hamilton W, Kernick D. Clinical features of primary brain tumours: a case-control study using electronic primary care records. Br J Gen Pract. 2007;57(542):695-9. PMID: 17761056; PMCID: PMC2151783
22. Kernick D, Stapley S, Goadsby PJ, Hamilton W. What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia. 2008;28(11):1188-95. DOI:10.1111/j.1468-2982.2008.01674.x
23. O'Flynn N, Ridsdale L. Headache in primary care: how important is diagnosis to management? Br J Gen Pract. 2002;52(480):569-73. PMID: 12120731; PMCID: PMC1314361
24. Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41(7):638-45.
DOI:10.1046/j.1526-4610.2001.041007638.x
25. Kernick D, Matharu MS, Goadsby PJ. Cluster headache in primary care: unmissable, underdiagnosed and undertreated. Br J Gen Pract. 2006;56(528):486-7. PMID: 16834873; PMCID: PMC1872057
26. Schreiber CP, Hutchinson S, Webster CJ, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache. Arch Intern Med. 2004;164(16):1769-72. DOI:10.1001/archinte.164.16.1769
27. Tepper SJ, Dahlöf CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache. 2004;44(9):856-64. DOI:10.1111/j.1526-4610.2004.04167.x
28. Ridsdale L, Clark LV, Dowson AJ, et al. How do patients referred to neurologists for headache differ from those managed in primary care? Br J Gen Pract. 2007;57(538):388-95. PMID: 17504590; PMCID: PMC2047014
29. Парфенов В.А., Неверовский Д.В. Ведение пациентов с дисциркуляторной энцефалопатией в амбулаторной практике. Неврология, нейропсихиатрия, психосоматика. 2015;1:37-42 [Parfenov VA, Neverovsky DV. Outpatient management of patients with dyscirculatory encephalopathy. Neurology, Neuropsychiatry, Psychosomatics. 2015;1:37-42 (in Russian)]. DOI:10.14412/2074-2711-2015-1-37-42
30. Парфенов В.А. Сосудистые когнитивные нарушения и хроническая ишемия головного мозга (дисциркуляторная энцефалопатия). Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):61-7 [Parfenov VA. Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy). Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):61-7 (in Russian)]. DOI:10.14412/2074-2711-2019-3S-61-67
31. Головачева В.А., Парфенов В.А. Хроническая ежедневная головная боль под маской дисциркуляторной энцефалопатии. Медицинский совет. 2015;2:72-7 [Golovacheva VA, Parfenov VA. Chronic daily headaches clinically simulating dyscirculatory encephalopathy. Medical Council. 2015;2:72-7 (in Russian)]. DOI:10.21518/2079-701X-2015-2-72-77
32. Манойлов А.Е. Утраченные критерии. Неврология, нейропсихиатрия, психосоматика. 2010;2(4):62-4 [Manoylov AE, Lost criteria. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):62-4 (in Russian)]. DOI:10.14412/2074-2711-2010-119
33. Парфенов В.А., Остроумова Т.М., Остроумова О.Д. Артериальная гипертензия и головная боль: влияние антигипертензивных препаратов. Рациональная фармакотерапия в кардиологии. 2019;15(3):416-23 [Parfenov VA, Ostroumova TM, Ostroumova OD. Hypertensionand Headache: the Effect of Antihypertensive Drugs. Rational Pharmacotherapy in Cardiology. 2019;15(3):416-23 (in Russian)]. DOI:10.20996/1819-6446-2019-15-3-416-423
34. Табеева Г.Р., Муранова А.В., Кострыгина Е.Н., Сергеев А.В. Мигрень и артериальная гипертензия. Неврология, нейропсихиатрия, психосоматика. 2015;7(4):4-10 [Tabeeva GR, Muranov AV, Kostrygina EN, Sergeev AV. Migraine and hypertension. Neurology, Neuropsychiatry, Psychosomatics. 2015;7(4):4-10 (in Russian)].
DOI:10.14412/2074-2711-2015-4-4-10
35. Остроумова Т.М., Остроумова О.Д., Парфенов В.А. Ранние признаки поражения головного мозга как органа-мишени при артериальной гипертензии. Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):32-7 [Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):32-7 (in Russian)]. DOI:10.14412/2074-2711-2019-3S-32-37
36. Dodick DW. Pearls: headache. Semin Neurol. 2010;30(1):74-81.DOI:10.1055/s-0029-1245000
37. Gago-Veiga AB, Camiña Muñiz J, García-Azorín D, et al. Headache: What to ask, how to examine, and which scales to use. Recommendations of the Spanish Society of Neurology's Headache Study Group. Neurologia (Engl Ed). 2019;S0213-4853(19)30024-6. DOI:10.1016/j.nrl.2018.12.006
38. Simon C, Everitt H, Kendrick T. Assessment of headache. In: Oxford Handbook of General Practice. 3rd ed. Oxford, GB: Oxford University Press, 2010; p. 560.
39. Toward Optimized Practice (TOP) Headache Working Group. Primary care management of headache in adults: clinical practice guideline. 2016. Available at: http://www.topalbertadoctors.org/cpgs/10065. Accessed: 31.11.2017.
40. Jordan JE, Flanders AE. Headache and Neuroimaging: Why We Continue to Do It. AJNR Am J Neuroradiol. 2020;41(7):1149-55. DOI:10.3174/ajnr.A6591
41. Expert Panel on Neurologic Imaging; Whitehead MT, Cardenas AM, Corey AS, et al. ACR Appropriateness Criteria® Headache. J Am Coll Radiol. 2019;16(11S):S364-77. DOI:10.1016/j.jacr.2019.05.030
42. Шагбазян А.Э., Ковальчук Н.А., Табеева Г.Р. Роль образовательных программ в ведении пациентов с медикаментозно-индуцированной головной болью. Неврология, нейропсихиатрия, психосоматика. 2021;13(3):27-33 [Shagbazyan AE, Kovalchuk NA, Tabeeva GR. Role of educational programs in management of patients with medication-overuse headache. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):27-33 (in Russian)]. DOI:10.14412/2074-2711-2021-3-27-33
43. Головачева В.А., Головачева А.А., Парфенов В.А., и др. Когнитивно-поведенческая терапия в лечении хронической мигрени: описание клинического случая. Неврология, нейропсихиатрия, психосоматика. 2021;13(1):74-80 [Golovacheva VA, Golovacheva AA, Parfenov VA, et al. Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):74-80 (in Russian)]. DOI:10.14412/2074-2711-2021-1-74-80
44. McNeil M. Headaches in Adults in Primary Care: Evaluation, Diagnosis, and Treatment. Med Clin North Am. 2021;105(1):39-53. DOI:10.1016/j.mcna.2020.09.005
45. Филатова Е.Г., Осипова В.В., Табеева Г.Р., и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):4-14 [Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Russian experts' recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4-14 (in Russian)]. DOI:10.14412/2074-2711-2020-4-4-14
46. Табеева Г.Р., Амелин А.В., Ахмадеева Л.Р., и др. Пути оптимизации ведения пациентов с мигренью в России (резолюция совета экспертов). Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(6):124-8 [Tabeeva GR, Amelin AV, Akhmadeeva LR, et al. Ways of optimizing the management of patients with migraine in Russia (resolution of the council of experts). Korsakov’s Journal of Neurology and Psychiatry. 2018;118(6):124-8 (in Russian)]. DOI:10.17116/jnevro201811861124
2. GBD 2019 Diseases and Injuries Collaborators. Global burden of
369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. DOI:10.1016/S0140-6736(20)30925-9
3. Martelletti P, Luciani M, Spuntarelli V, Bentivegna E. Deprescribing in migraine. Expert Opin Drug Saf. 2021;20(6):623-5. DOI:10.1080/14740338.2021.1907342
4. GBD 2016 Headache Collaborators. Global, Regional, and National Burden of Migraine and Tension-Type Headache, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-76. DOI:10.1016/S1474-4422(18)30322-3
5. Steiner TJ, Stovner LJ, Jensen R, et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137. DOI:10.1186/s10194-020-01208-0
6. Latinovic R, Gulliford M, Ridsdale L. Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry. 2006;77(3):385-7. DOI:10.1136/jnnp.2005.073221
7. Lebedeva ER, Kobzeva NR, Gilev DV, Olesen E. Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural Region. Neurology, Neuropsychiatry, Psychosomatics. 2015;1:19-26 (in Russian). DOI:10.14412/2074-2711-2015-1-19-26
8. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193-210. DOI:10.1111/j.1468-2982.2007.01288.x
9. Lucas C, Geraud G, Valade D, et al. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French Nationwide Population-Based Survey. Headache. 2006;46:715-25. DOI:10.1111/j.1526-4610.2006.00430.x
10. Kovalchuk NA, Kiryanova EA, Tabeeva GR. Medication adherence in migraine patients (data of an online survey). Neurology, Neuropsychiatry, Psychosomatics. 2021;13(4):81-7 (in Russian).DOI:10.14412/2074- 2711-2021-4-81-87
11. McNeil M. Headaches in Adults in Primary Care: Evaluation, Diagnosis, and Treatment. Med Clin North Am. 2021;105(1):39-53. DOI:10.1016/j.mcna.2020.09.005
12. Fejes E, Feher G, Gurdan Z, et al. Characteristics of Patients Referred To A Specialized Headache Clinic. Sci Rep. 2020;10(1):1146. DOI:10.1038/s41598-020-58234-w
13. Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53(3):427-36. DOI:10.1111/head.12074
14. Green LA, Phillips RL, Fryer GE. The nature of primary medical care. In: Oxford Textbook of Primary Medical Care. Oxford University Press, Oxford, UK, 2005.
15. BeckerL A, Iverson DC, Reed FM, et al. Study of Headache in North America in primary care. J R Coll Gen Pract. 1987;37:400-3.
16. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018;38(1):1-211. DOI:10.1177/0333102417738202
17. Steiner TJ, Jensen R, Katsarava Z, et al. Aids to management of headache disorders in primary care (2nd edition). J Headache Pain. 2019;20:57.
DOI:10.1186/s10194-018-0899-2
18. Steiner TJ, Paemeleire K, Jensen R, et al. European principles of management of common headache disorders in primary care. J Headache Pain. 2007;8(Suppl. 1).
19. Becker WJ, Findlay T, Moga C, et al. Guideline for primary care management of headache in adults. Can Fam Physician. 2015;61(8):670-9. PMID: 26273080; PMCID: PMC4541429
20. Kernick D, Stapley S, Hamilton W. GPs' classification of headache: is primary headache underdiagnosed? Br J Gen Pract. 2008;58(547):102-4. DOI:10.3399/bjgp08X264072
21. Hamilton W, Kernick D. Clinical features of primary brain tumours: a case-control study using electronic primary care records. Br J Gen Pract. 2007;57(542):695-9. PMID: 17761056; PMCID: PMC2151783
22. Kernick D, Stapley S, Goadsby PJ, Hamilton W. What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia. 2008;28(11):1188-95. DOI:10.1111/j.1468-2982.2008.01674.x
23. O'Flynn N, Ridsdale L. Headache in primary care: how important is diagnosis to management? Br J Gen Pract. 2002;52(480):569-73. PMID: 12120731; PMCID: PMC1314361
24. Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41(7):638-45.
DOI:10.1046/j.1526-4610.2001.041007638.x
25. Kernick D, Matharu MS, Goadsby PJ. Cluster headache in primary care: unmissable, underdiagnosed and undertreated. Br J Gen Pract. 2006;56(528):486-7. PMID: 16834873; PMCID: PMC1872057
26. Schreiber CP, Hutchinson S, Webster CJ, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache. Arch Intern Med. 2004;164(16):1769-72. DOI:10.1001/archinte.164.16.1769
27. Tepper SJ, Dahlöf CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache. 2004;44(9):856-64. DOI:10.1111/j.1526-4610.2004.04167.x
28. Ridsdale L, Clark LV, Dowson AJ, et al. How do patients referred to neurologists for headache differ from those managed in primary care? Br J Gen Pract. 2007;57(538):388-95. PMID: 17504590; PMCID: PMC2047014
29. Parfenov VA, Neverovsky DV. Outpatient management of patients with dyscirculatory encephalopathy. Neurology, Neuropsychiatry, Psychosomatics. 2015;1:37-42 (in Russian). DOI:10.14412/2074-2711-2015-1-37-42
30. Parfenov VA. Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy). Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):61-7 (in Russian). DOI:10.14412/2074-2711-2019-3S-61-67
31. Golovacheva VA, Parfenov VA. Chronic daily headaches clinically simulating dyscirculatory encephalopathy. Medical Council. 2015;2:72-7 (in Russian). DOI:10.21518/2079-701X-2015-2-72-77
32. Manoylov AE, Lost criteria. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):62-4 (in Russian). DOI:10.14412/2074-2711-2010-119
33. Parfenov VA, Ostroumova TM, Ostroumova OD. Hypertensionand Headache: the Effect of Antihypertensive Drugs. Rational Pharmacotherapy in Cardiology. 2019;15(3):416-23 (in Russian). DOI:10.20996/1819-6446-2019-15-3-416-423
34. Tabeeva GR, Muranov AV, Kostrygina EN, Sergeev AV. Migraine and hypertension. Neurology, Neuropsychiatry, Psychosomatics. 2015;7(4):4-10 (in Russian).
DOI:10.14412/2074-2711-2015-4-4-10
35. Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):32-7 (in Russian). DOI:10.14412/2074-2711-2019-3S-32-37
36. Dodick DW. Pearls: headache. Semin Neurol. 2010;30(1):74-81.DOI:10.1055/s-0029-1245000
37. Gago-Veiga AB, Camiña Muñiz J, García-Azorín D, et al. Headache: What to ask, how to examine, and which scales to use. Recommendations of the Spanish Society of Neurology's Headache Study Group. Neurologia (Engl Ed). 2019;S0213-4853(19)30024-6. DOI:10.1016/j.nrl.2018.12.006
38. Simon C, Everitt H, Kendrick T. Assessment of headache. In: Oxford Handbook of General Practice. 3rd ed. Oxford, GB: Oxford University Press, 2010; p. 560.
39. Toward Optimized Practice (TOP) Headache Working Group. Primary care management of headache in adults: clinical practice guideline. 2016. Available at: http://www.topalbertadoctors.org/cpgs/10065. Accessed: 31.11.2017.
40. Jordan JE, Flanders AE. Headache and Neuroimaging: Why We Continue to Do It. AJNR Am J Neuroradiol. 2020;41(7):1149-55. DOI:10.3174/ajnr.A6591
41. Expert Panel on Neurologic Imaging; Whitehead MT, Cardenas AM, Corey AS, et al. ACR Appropriateness Criteria® Headache. J Am Coll Radiol. 2019;16(11S):S364-77. DOI:10.1016/j.jacr.2019.05.030
42. Shagbazyan AE, Kovalchuk NA, Tabeeva GR. Role of educational programs in management of patients with medication-overuse headache. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):27-33 (in Russian). DOI:10.14412/2074-2711-2021-3-27-33
43. Golovacheva VA, Golovacheva AA, Parfenov VA, et al. Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):74-80 (in Russian). DOI:10.14412/2074-2711-2021-1-74-80
44. McNeil M. Headaches in Adults in Primary Care: Evaluation, Diagnosis, and Treatment. Med Clin North Am. 2021;105(1):39-53. DOI:10.1016/j.mcna.2020.09.005
45. Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Russian experts' recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4-14 (in Russian). DOI:10.14412/2074-2711-2020-4-4-14
46. Tabeeva GR, Amelin AV, Akhmadeeva LR, et al. Ways of optimizing the management of patients with migraine in Russia (resolution of the council of experts). Korsakov’s Journal of Neurology and Psychiatry. 2018;118(6):124-8 (inRussian).
DOI:10.17116/jnevro201811861124
2. GBD 2019 Diseases and Injuries Collaborators. Global burden of
369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. DOI:10.1016/S0140-6736(20)30925-9
3. Martelletti P, Luciani M, Spuntarelli V, Bentivegna E. Deprescribing in migraine. Expert Opin Drug Saf. 2021;20(6):623-5. DOI:10.1080/14740338.2021.1907342
4. GBD 2016 Headache Collaborators. Global, Regional, and National Burden of Migraine and Tension-Type Headache, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-76. DOI:10.1016/S1474-4422(18)30322-3
5. Steiner TJ, Stovner LJ, Jensen R, et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137. DOI:10.1186/s10194-020-01208-0
6. Latinovic R, Gulliford M, Ridsdale L. Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry. 2006;77(3):385-7. DOI:10.1136/jnnp.2005.073221
7. Лебедева Е.Р., Кобзева Н.Р., Гилев Д.В., Олесен Е. Анализ качества диагностики и лечения первичной головной боли в разных социальных группах Уральского региона. Неврология, нейропсихиатрия, психосоматика. 2015;1:19-26 [Lebedeva ER, Kobzeva NR, Gilev DV, Olesen E. Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural Region. Neurology, Neuropsychiatry, Psychosomatics. 2015;1:19-26 (in Russian)]. DOI:10.14412/2074-2711-2015-1-19-26
8. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193-210. DOI:10.1111/j.1468-2982.2007.01288.x
9. Lucas C, Geraud G, Valade D, et al. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French Nationwide Population-Based Survey. Headache. 2006;46:715-25. DOI:10.1111/j.1526-4610.2006.00430.x
10. Ковальчук Н.А., Кирьянова Е.А., Табеева Г.Р. Приверженность терапии пациентов с мигренью (по данным интернет-опроса). Неврология, нейропсихиатрия, психосоматика. 2021;13(4):81-7 [Kovalchuk NA, Kiryanova EA, Tabeeva GR. Medication adherence in migraine patients (data of an online survey). Neurology, Neuropsychiatry, Psychosomatics. 2021;13(4):81-7 (in Russian)].DOI:10.14412/2074- 2711-2021-4-81-87
11. McNeil M. Headaches in Adults in Primary Care: Evaluation, Diagnosis, and Treatment. Med Clin North Am. 2021;105(1):39-53. DOI:10.1016/j.mcna.2020.09.005
12. Fejes E, Feher G, Gurdan Z, et al. Characteristics of Patients Referred To A Specialized Headache Clinic. Sci Rep. 2020;10(1):1146. DOI:10.1038/s41598-020-58234-w
13. Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53(3):427-36. DOI:10.1111/head.12074
14. Green LA, Phillips RL, Fryer GE. The nature of primary medical care. In: Oxford Textbook of Primary Medical Care. Oxford University Press, Oxford, UK, 2005.
15. BeckerL A, Iverson DC, Reed FM, et al. Study of Headache in North America in primary care. J R Coll Gen Pract. 1987;37:400-3.
16. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018;38(1):1-211. DOI:10.1177/0333102417738202
17. Steiner TJ, Jensen R, Katsarava Z, et al. Aids to management of headache disorders in primary care (2nd edition). J Headache Pain. 2019;20:57.
DOI:10.1186/s10194-018-0899-2
18. Стайнер Т.Дж., Пемелера К., Йенсен Р., и др. Европейские принципы ведения пациентов с наиболее распространенными формами головной боли в общей практике. Практическое руководство для врачей. Пер. с англ. Ю.Э. Азимовой, В.В. Осиповой; науч. ред. В.В. Осипова, Т.Г. Вознесенская, Г.Р. Табеева. М., 2010 [Steiner TJ, Paemeleire K, Jensen R, et al. European principles of management of common headache disorders in primary care. J Headache Pain. 2007;8(Suppl. 1)].
19. Becker WJ, Findlay T, Moga C, et al. Guideline for primary care management of headache in adults. Can Fam Physician. 2015;61(8):670-9. PMID: 26273080; PMCID: PMC4541429
20. Kernick D, Stapley S, Hamilton W. GPs' classification of headache: is primary headache underdiagnosed? Br J Gen Pract. 2008;58(547):102-4. DOI:10.3399/bjgp08X264072
21. Hamilton W, Kernick D. Clinical features of primary brain tumours: a case-control study using electronic primary care records. Br J Gen Pract. 2007;57(542):695-9. PMID: 17761056; PMCID: PMC2151783
22. Kernick D, Stapley S, Goadsby PJ, Hamilton W. What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia. 2008;28(11):1188-95. DOI:10.1111/j.1468-2982.2008.01674.x
23. O'Flynn N, Ridsdale L. Headache in primary care: how important is diagnosis to management? Br J Gen Pract. 2002;52(480):569-73. PMID: 12120731; PMCID: PMC1314361
24. Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41(7):638-45.
DOI:10.1046/j.1526-4610.2001.041007638.x
25. Kernick D, Matharu MS, Goadsby PJ. Cluster headache in primary care: unmissable, underdiagnosed and undertreated. Br J Gen Pract. 2006;56(528):486-7. PMID: 16834873; PMCID: PMC1872057
26. Schreiber CP, Hutchinson S, Webster CJ, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache. Arch Intern Med. 2004;164(16):1769-72. DOI:10.1001/archinte.164.16.1769
27. Tepper SJ, Dahlöf CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache. 2004;44(9):856-64. DOI:10.1111/j.1526-4610.2004.04167.x
28. Ridsdale L, Clark LV, Dowson AJ, et al. How do patients referred to neurologists for headache differ from those managed in primary care? Br J Gen Pract. 2007;57(538):388-95. PMID: 17504590; PMCID: PMC2047014
29. Парфенов В.А., Неверовский Д.В. Ведение пациентов с дисциркуляторной энцефалопатией в амбулаторной практике. Неврология, нейропсихиатрия, психосоматика. 2015;1:37-42 [Parfenov VA, Neverovsky DV. Outpatient management of patients with dyscirculatory encephalopathy. Neurology, Neuropsychiatry, Psychosomatics. 2015;1:37-42 (in Russian)]. DOI:10.14412/2074-2711-2015-1-37-42
30. Парфенов В.А. Сосудистые когнитивные нарушения и хроническая ишемия головного мозга (дисциркуляторная энцефалопатия). Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):61-7 [Parfenov VA. Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy). Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):61-7 (in Russian)]. DOI:10.14412/2074-2711-2019-3S-61-67
31. Головачева В.А., Парфенов В.А. Хроническая ежедневная головная боль под маской дисциркуляторной энцефалопатии. Медицинский совет. 2015;2:72-7 [Golovacheva VA, Parfenov VA. Chronic daily headaches clinically simulating dyscirculatory encephalopathy. Medical Council. 2015;2:72-7 (in Russian)]. DOI:10.21518/2079-701X-2015-2-72-77
32. Манойлов А.Е. Утраченные критерии. Неврология, нейропсихиатрия, психосоматика. 2010;2(4):62-4 [Manoylov AE, Lost criteria. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):62-4 (in Russian)]. DOI:10.14412/2074-2711-2010-119
33. Парфенов В.А., Остроумова Т.М., Остроумова О.Д. Артериальная гипертензия и головная боль: влияние антигипертензивных препаратов. Рациональная фармакотерапия в кардиологии. 2019;15(3):416-23 [Parfenov VA, Ostroumova TM, Ostroumova OD. Hypertensionand Headache: the Effect of Antihypertensive Drugs. Rational Pharmacotherapy in Cardiology. 2019;15(3):416-23 (in Russian)]. DOI:10.20996/1819-6446-2019-15-3-416-423
34. Табеева Г.Р., Муранова А.В., Кострыгина Е.Н., Сергеев А.В. Мигрень и артериальная гипертензия. Неврология, нейропсихиатрия, психосоматика. 2015;7(4):4-10 [Tabeeva GR, Muranov AV, Kostrygina EN, Sergeev AV. Migraine and hypertension. Neurology, Neuropsychiatry, Psychosomatics. 2015;7(4):4-10 (in Russian)].
DOI:10.14412/2074-2711-2015-4-4-10
35. Остроумова Т.М., Остроумова О.Д., Парфенов В.А. Ранние признаки поражения головного мозга как органа-мишени при артериальной гипертензии. Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):32-7 [Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):32-7 (in Russian)]. DOI:10.14412/2074-2711-2019-3S-32-37
36. Dodick DW. Pearls: headache. Semin Neurol. 2010;30(1):74-81.DOI:10.1055/s-0029-1245000
37. Gago-Veiga AB, Camiña Muñiz J, García-Azorín D, et al. Headache: What to ask, how to examine, and which scales to use. Recommendations of the Spanish Society of Neurology's Headache Study Group. Neurologia (Engl Ed). 2019;S0213-4853(19)30024-6. DOI:10.1016/j.nrl.2018.12.006
38. Simon C, Everitt H, Kendrick T. Assessment of headache. In: Oxford Handbook of General Practice. 3rd ed. Oxford, GB: Oxford University Press, 2010; p. 560.
39. Toward Optimized Practice (TOP) Headache Working Group. Primary care management of headache in adults: clinical practice guideline. 2016. Available at: http://www.topalbertadoctors.org/cpgs/10065. Accessed: 31.11.2017.
40. Jordan JE, Flanders AE. Headache and Neuroimaging: Why We Continue to Do It. AJNR Am J Neuroradiol. 2020;41(7):1149-55. DOI:10.3174/ajnr.A6591
41. Expert Panel on Neurologic Imaging; Whitehead MT, Cardenas AM, Corey AS, et al. ACR Appropriateness Criteria® Headache. J Am Coll Radiol. 2019;16(11S):S364-77. DOI:10.1016/j.jacr.2019.05.030
42. Шагбазян А.Э., Ковальчук Н.А., Табеева Г.Р. Роль образовательных программ в ведении пациентов с медикаментозно-индуцированной головной болью. Неврология, нейропсихиатрия, психосоматика. 2021;13(3):27-33 [Shagbazyan AE, Kovalchuk NA, Tabeeva GR. Role of educational programs in management of patients with medication-overuse headache. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):27-33 (in Russian)]. DOI:10.14412/2074-2711-2021-3-27-33
43. Головачева В.А., Головачева А.А., Парфенов В.А., и др. Когнитивно-поведенческая терапия в лечении хронической мигрени: описание клинического случая. Неврология, нейропсихиатрия, психосоматика. 2021;13(1):74-80 [Golovacheva VA, Golovacheva AA, Parfenov VA, et al. Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):74-80 (in Russian)]. DOI:10.14412/2074-2711-2021-1-74-80
44. McNeil M. Headaches in Adults in Primary Care: Evaluation, Diagnosis, and Treatment. Med Clin North Am. 2021;105(1):39-53. DOI:10.1016/j.mcna.2020.09.005
45. Филатова Е.Г., Осипова В.В., Табеева Г.Р., и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):4-14 [Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Russian experts' recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4-14 (in Russian)]. DOI:10.14412/2074-2711-2020-4-4-14
46. Табеева Г.Р., Амелин А.В., Ахмадеева Л.Р., и др. Пути оптимизации ведения пациентов с мигренью в России (резолюция совета экспертов). Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(6):124-8 [Tabeeva GR, Amelin AV, Akhmadeeva LR, et al. Ways of optimizing the management of patients with migraine in Russia (resolution of the council of experts). Korsakov’s Journal of Neurology and Psychiatry. 2018;118(6):124-8 (in Russian)]. DOI:10.17116/jnevro201811861124
________________________________________________
2. GBD 2019 Diseases and Injuries Collaborators. Global burden of
369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. DOI:10.1016/S0140-6736(20)30925-9
3. Martelletti P, Luciani M, Spuntarelli V, Bentivegna E. Deprescribing in migraine. Expert Opin Drug Saf. 2021;20(6):623-5. DOI:10.1080/14740338.2021.1907342
4. GBD 2016 Headache Collaborators. Global, Regional, and National Burden of Migraine and Tension-Type Headache, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-76. DOI:10.1016/S1474-4422(18)30322-3
5. Steiner TJ, Stovner LJ, Jensen R, et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137. DOI:10.1186/s10194-020-01208-0
6. Latinovic R, Gulliford M, Ridsdale L. Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry. 2006;77(3):385-7. DOI:10.1136/jnnp.2005.073221
7. Lebedeva ER, Kobzeva NR, Gilev DV, Olesen E. Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural Region. Neurology, Neuropsychiatry, Psychosomatics. 2015;1:19-26 (in Russian). DOI:10.14412/2074-2711-2015-1-19-26
8. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193-210. DOI:10.1111/j.1468-2982.2007.01288.x
9. Lucas C, Geraud G, Valade D, et al. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French Nationwide Population-Based Survey. Headache. 2006;46:715-25. DOI:10.1111/j.1526-4610.2006.00430.x
10. Kovalchuk NA, Kiryanova EA, Tabeeva GR. Medication adherence in migraine patients (data of an online survey). Neurology, Neuropsychiatry, Psychosomatics. 2021;13(4):81-7 (in Russian).DOI:10.14412/2074- 2711-2021-4-81-87
11. McNeil M. Headaches in Adults in Primary Care: Evaluation, Diagnosis, and Treatment. Med Clin North Am. 2021;105(1):39-53. DOI:10.1016/j.mcna.2020.09.005
12. Fejes E, Feher G, Gurdan Z, et al. Characteristics of Patients Referred To A Specialized Headache Clinic. Sci Rep. 2020;10(1):1146. DOI:10.1038/s41598-020-58234-w
13. Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53(3):427-36. DOI:10.1111/head.12074
14. Green LA, Phillips RL, Fryer GE. The nature of primary medical care. In: Oxford Textbook of Primary Medical Care. Oxford University Press, Oxford, UK, 2005.
15. BeckerL A, Iverson DC, Reed FM, et al. Study of Headache in North America in primary care. J R Coll Gen Pract. 1987;37:400-3.
16. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018;38(1):1-211. DOI:10.1177/0333102417738202
17. Steiner TJ, Jensen R, Katsarava Z, et al. Aids to management of headache disorders in primary care (2nd edition). J Headache Pain. 2019;20:57.
DOI:10.1186/s10194-018-0899-2
18. Steiner TJ, Paemeleire K, Jensen R, et al. European principles of management of common headache disorders in primary care. J Headache Pain. 2007;8(Suppl. 1).
19. Becker WJ, Findlay T, Moga C, et al. Guideline for primary care management of headache in adults. Can Fam Physician. 2015;61(8):670-9. PMID: 26273080; PMCID: PMC4541429
20. Kernick D, Stapley S, Hamilton W. GPs' classification of headache: is primary headache underdiagnosed? Br J Gen Pract. 2008;58(547):102-4. DOI:10.3399/bjgp08X264072
21. Hamilton W, Kernick D. Clinical features of primary brain tumours: a case-control study using electronic primary care records. Br J Gen Pract. 2007;57(542):695-9. PMID: 17761056; PMCID: PMC2151783
22. Kernick D, Stapley S, Goadsby PJ, Hamilton W. What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia. 2008;28(11):1188-95. DOI:10.1111/j.1468-2982.2008.01674.x
23. O'Flynn N, Ridsdale L. Headache in primary care: how important is diagnosis to management? Br J Gen Pract. 2002;52(480):569-73. PMID: 12120731; PMCID: PMC1314361
24. Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41(7):638-45.
DOI:10.1046/j.1526-4610.2001.041007638.x
25. Kernick D, Matharu MS, Goadsby PJ. Cluster headache in primary care: unmissable, underdiagnosed and undertreated. Br J Gen Pract. 2006;56(528):486-7. PMID: 16834873; PMCID: PMC1872057
26. Schreiber CP, Hutchinson S, Webster CJ, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache. Arch Intern Med. 2004;164(16):1769-72. DOI:10.1001/archinte.164.16.1769
27. Tepper SJ, Dahlöf CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache. 2004;44(9):856-64. DOI:10.1111/j.1526-4610.2004.04167.x
28. Ridsdale L, Clark LV, Dowson AJ, et al. How do patients referred to neurologists for headache differ from those managed in primary care? Br J Gen Pract. 2007;57(538):388-95. PMID: 17504590; PMCID: PMC2047014
29. Parfenov VA, Neverovsky DV. Outpatient management of patients with dyscirculatory encephalopathy. Neurology, Neuropsychiatry, Psychosomatics. 2015;1:37-42 (in Russian). DOI:10.14412/2074-2711-2015-1-37-42
30. Parfenov VA. Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy). Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):61-7 (in Russian). DOI:10.14412/2074-2711-2019-3S-61-67
31. Golovacheva VA, Parfenov VA. Chronic daily headaches clinically simulating dyscirculatory encephalopathy. Medical Council. 2015;2:72-7 (in Russian). DOI:10.21518/2079-701X-2015-2-72-77
32. Manoylov AE, Lost criteria. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):62-4 (in Russian). DOI:10.14412/2074-2711-2010-119
33. Parfenov VA, Ostroumova TM, Ostroumova OD. Hypertensionand Headache: the Effect of Antihypertensive Drugs. Rational Pharmacotherapy in Cardiology. 2019;15(3):416-23 (in Russian). DOI:10.20996/1819-6446-2019-15-3-416-423
34. Tabeeva GR, Muranov AV, Kostrygina EN, Sergeev AV. Migraine and hypertension. Neurology, Neuropsychiatry, Psychosomatics. 2015;7(4):4-10 (in Russian).
DOI:10.14412/2074-2711-2015-4-4-10
35. Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):32-7 (in Russian). DOI:10.14412/2074-2711-2019-3S-32-37
36. Dodick DW. Pearls: headache. Semin Neurol. 2010;30(1):74-81.DOI:10.1055/s-0029-1245000
37. Gago-Veiga AB, Camiña Muñiz J, García-Azorín D, et al. Headache: What to ask, how to examine, and which scales to use. Recommendations of the Spanish Society of Neurology's Headache Study Group. Neurologia (Engl Ed). 2019;S0213-4853(19)30024-6. DOI:10.1016/j.nrl.2018.12.006
38. Simon C, Everitt H, Kendrick T. Assessment of headache. In: Oxford Handbook of General Practice. 3rd ed. Oxford, GB: Oxford University Press, 2010; p. 560.
39. Toward Optimized Practice (TOP) Headache Working Group. Primary care management of headache in adults: clinical practice guideline. 2016. Available at: http://www.topalbertadoctors.org/cpgs/10065. Accessed: 31.11.2017.
40. Jordan JE, Flanders AE. Headache and Neuroimaging: Why We Continue to Do It. AJNR Am J Neuroradiol. 2020;41(7):1149-55. DOI:10.3174/ajnr.A6591
41. Expert Panel on Neurologic Imaging; Whitehead MT, Cardenas AM, Corey AS, et al. ACR Appropriateness Criteria® Headache. J Am Coll Radiol. 2019;16(11S):S364-77. DOI:10.1016/j.jacr.2019.05.030
42. Shagbazyan AE, Kovalchuk NA, Tabeeva GR. Role of educational programs in management of patients with medication-overuse headache. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):27-33 (in Russian). DOI:10.14412/2074-2711-2021-3-27-33
43. Golovacheva VA, Golovacheva AA, Parfenov VA, et al. Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):74-80 (in Russian). DOI:10.14412/2074-2711-2021-1-74-80
44. McNeil M. Headaches in Adults in Primary Care: Evaluation, Diagnosis, and Treatment. Med Clin North Am. 2021;105(1):39-53. DOI:10.1016/j.mcna.2020.09.005
45. Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Russian experts' recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4-14 (in Russian). DOI:10.14412/2074-2711-2020-4-4-14
46. Tabeeva GR, Amelin AV, Akhmadeeva LR, et al. Ways of optimizing the management of patients with migraine in Russia (resolution of the council of experts). Korsakov’s Journal of Neurology and Psychiatry. 2018;118(6):124-8 (inRussian).
DOI:10.17116/jnevro201811861124
Авторы
Г.Р. Табеева*
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
*grtabeeva@gmail.com
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
*grtabeeva@gmail.com
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
*grtabeeva@gmail.com
________________________________________________
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
*grtabeeva@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.